Investor Presentaiton

Investor Presentation First nine months of 2018 Slide 81 The GLP-1 segment accounts for around 6% of the total diabetes care market in Region Japan & Korea Region Japan & Korea GLP-1 market GLP-1 value in bDKK VictozaⓇ Exenatide Dulaglutide Other VictozaⓇ value market share in Region Japan & Korea VictozaⓇ Exenatide Dulaglutide Other Share of total diabetes care GLP-1 value market share market 1.8 4% 100% 1.6 3% 1.4 CAGR value¹: 27.6% 80% 3% 1.2 60% 1.0 2% 0.8 2% 40% 0.6 1% 0.4 20% 1% 0.2 0.0 0% 0% Aug 2013 Aug 2018 Aug 2013 1 CAGR for 5-year period Source: IQVIA monthly MAT Aug, 2018 value figures (DKK) changing diabetes® Source: IQVIA monthly MAT Aug, 2018 value figures (DKK) 59% 34% 4% 3% Aug 2018 novo nordisk

View entire presentation